Renegade.bio Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
17
- Latest Deal Type
-
Out of Business
Renegade.bio General Information
Description
Operator of a biotechnology startup intended to develop and deploy diagnostics for the detection of novel infectious diseases. The company develops novel diagnostics and assays that support drug development, leveraging capabilities and experience in biomarker discovery, polymerase chain reaction (PCR), next-generation sequencing (NGS), and liquid chromatography-mass spectrometry (LC-MS), enabling healthcare organizations to provide diagnostic testing for individuals, workplaces, schools, communities, events, concerts, and festivals.
Contact Information
Website
www.renegade.bioCorporate Office
- 829 Heinz Avenue
- Berkeley, CA 94710
- United States
Corporate Office
- 829 Heinz Avenue
- Berkeley, CA 94710
- United States
Renegade.bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 25-Apr-2026 | Completed | Out of Business | |||
| 4. Later Stage VC | 29-Feb-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 01-Mar-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | $275K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Jan-2016 | $275K | $275K | Completed | Startup |
Renegade.bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
Renegade.bio Comparisons
Industry
Financing
Details
Renegade.bio Competitors (1)
One of Renegade.bio’s competitors is Accurie Bio, a Venture Capital-Backed company based in Gwangmyeong, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accurie Bio | Venture Capital-Backed | Gwangmyeong, South Korea |
Renegade.bio Patents
Renegade.bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1101963-S1 | Package of sample shipping kit | Active | 17-Aug-2023 | ||
| WO-2025038922-A1 | Sample collection kit | Inactive | 17-Aug-2023 | ||
| CA-228229-S | Sample shipping kit | Active | 17-Aug-2023 | ||
| US-20240068055-A1 | Qualitative, multiplex reverse transcription pcr for the differential detection of the orthopox virus monkeypox | Inactive | 04-Aug-2022 | ||
| WO-2024015491-A1 | Sample collection apparatus | Inactive | 13-Jul-2022 | B01L3/5023 |
Renegade.bio Signals
Renegade.bio Acquisitions (1)
Renegade.bio’s most recent deal was a Merger/Acquisition with Weavr Health. The deal was made on 23-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Weavr Health | 23-Mar-2023 | Merger/Acquisition | Diagnostic Equipment |
Renegade.bio FAQs
-
When was Renegade.bio founded?
Renegade.bio was founded in 2016.
-
Where is Renegade.bio headquartered?
Renegade.bio is headquartered in Berkeley, CA.
-
What is the size of Renegade.bio?
Renegade.bio has 17 total employees.
-
What industry is Renegade.bio in?
Renegade.bio’s primary industry is Diagnostic Equipment.
-
Is Renegade.bio a private or public company?
Renegade.bio is a Private company.
-
What is Renegade.bio’s current revenue?
The current revenue for Renegade.bio is .
-
How much funding has Renegade.bio raised over time?
Renegade.bio has raised $28.9M.
-
Who are Renegade.bio’s competitors?
Accurie Bio is a competitor of Renegade.bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process